All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

Lewden, Charlotte ; Bouteloup, Vincent ; De Wit, Stéphane ; Sabin, Caroline ; Mocroft, Amanda ; Wasmuth, Jan Christian ; van Sighem, Ard ; Kirk, Ole ; Obel, Niels ; Panos, George ; Ghosn, Jade ; Dabis, François ; Mary-Krause, Murielle ; Leport, Catherine ; Perez-Hoyos, Santiago ; Sobrino-Vegas, Paz ; Stephan, Christoph ; Castagna, Antonella ; Antinori, Andrea ; d'Arminio Monforte, Antonella ; Torti, Carlo ; Mussini, Cristina ; Isern, Virginia ; Calmy, Alexandra ; Teira, Ramón ; Egger, Matthias ; Grarup, Jesper ; Chêne, Geneviève

In: International Journal of Epidemiology, 2012, vol. 41, no. 2, p. 433-445

Add to personal list
    Background Using data from a large European collaborative study, we aimed to identify the circumstances in which treated HIV-infected individuals will experience similar mortality rates to those of the general population. Methods Adults were eligible if they initiated combination anti-retroviral treatment (cART) between 1998 and 2008 and had one prior CD4 measurement within 6 months. Standardized mortality ratios (SMRs) and excess mortality rates compared with the general population were estimated using Poisson regression. Periods of follow-up were classified according to the current CD4 count. Results Of the 80 642 individuals, 70% were men, 16% were injecting drug users (IDUs), the median age was 37 years, median CD4 count 225/mm3 at cART initiation and median follow-up was 3.5 years. The overall mortality rate was 1.2/100 person-years (PY) (men: 1.3, women: 0.9), 4.2 times as high as that in the general population (SMR for men: 3.8, for women: 7.4). Among 35 316 individuals with a CD4 count ≥500/mm3, the mortality rate was 0.37/100 PY (SMR 1.5); mortality rates were similar to those of the general population in non-IDU men [SMR 0.9, 95% confidence interval (95% CI) 0.7-1.3] and, after 3 years, in women (SMR 1.1, 95% CI 0.7-1.7). Mortality rates in IDUs remained elevated, though a trend to decrease with longer durations with high CD4 count was seen. A prior AIDS diagnosis was associated with higher mortality. Conclusions Mortality patterns in most non-IDU HIV-infected individuals with high CD4 counts on cART are similar to those in the general population. The persistent role of a prior AIDS diagnosis underlines the importance of early diagnosis of HIV infection